A top-notch restructuring group, capable of handling the biggest and the most difficult restructuring from either company side or creditors’ side. 
- Chambers USA, Band 1 Bankruptcy/Restructuring (Nationwide and NY)
Healthcare & Pharmaceutical
Our restructuring department fields large, multidisciplinary teams that leverage the resources of our firm as a whole. We act on all sides of cutting-edge restructuring transactions across a range of industries.
-
Chapter 11 Cases of Endo Pharmaceuticals
An ad hoc group of first lien, second lien, and unsecured lenders in the chapter 11 restructuring of Endo Pharmaceuticals, a specialty pharmaceutical company. The group comprised approximately of $3.2 billion, nearly forty percent, of the company’s funded debt.
-
Rite Aid's Restructuring
An ad hoc group of second lien noteholders of Rite Aid Corporation, a full-service pharmacy company providing a broad range of services, including retail pharmacy, PBM, and mail order, across 17 states, in connection with its restructuring of $3.4 billion of total funded debt, including $1.05 billion held by the ad hoc group.
-
SmileDirectClub's Restructuring
An ad hoc committee of holders of unsecured convertible notes issued by SmileDirectClub (“SDC”), which filed for chapter 11 in the Southern District of Texas.
-
Envision Healthcare's Chapter 11 Cases
KKR, as sponsor to Envision Healthcare, in connection with Envision’s chapter 11 cases.
-
Genesis Care's Chapter 11 Cases
KKR, as shareholder and prepetition lender to GenesisCare, an Australia-based operator of cancer treatment centers, in its chapter 11 cases.
-
Clovis Oncology's Chapter 11 Cases and Sale
An ad hoc group of convertible noteholders of Clovis Oncology, a specialty pharmaceutical company, in the company's chapter 11 cases and related sale process.
-
Chapter 11 Cases of the Center for Autism and Related Disorders
Funds or accounts affiliated with Blackstone in the chapter 11 cases of Center for Autism and Related Disorders, one of the nation’s largest treatment providers for individuals diagnosed with autism spectrum disorder.
-
Envision Healthcare Financing
KKR, as sponsor to Envision Healthcare, in connection with Envision’s entry into $2.6 billion, in aggregate, of new senior secured first and second lien financing facilities and its $1.5 billion of related discounted debt repurchase transactions and $3.7 billion refinancing transaction.
-
The Stayton
The successor bond trustee and an ad hoc group of certain holders of Tarrant County Cultural Education Facilities Financial Corporation Retirement Revenue Bonds (The Stayton at Museum Way Project), Series 2020 Bonds, in connection with safeguarding their interests in respect of Series 2020 Bonds and The Stayton, a continuing care retirement community.
-
Bausch Healthcare Spin-Off
An ad hoc group of secured and unsecured creditors of Bausch Health, a multinational healthcare company, in connection with the company’s proposed spin-off of its eyecare business.
